We are live on ! Find out more
PXMD

PaxMedica, Inc. Common Stock
PXMD

Delisted

PXMD was delisted on the 1st of May, 2024.

Back to rankings

8 hedge funds and large institutions have $165K invested in PaxMedica, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

20% less funds holding

Funds holding: 10 → 8 (-2)

46% less capital invested

Capital invested by funds: $308K → $165K (-$142K)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$99.5K
2
HF
HRT Financial
New York
+$37.5K
3
TRCT
Tower Research Capital (TRC)
New York
+$5.39K
4
Wells Fargo
Wells Fargo
California
+$25

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$33.9K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$26.1K
3
VF
Virtu Financial
New York
-$24K
4
Bank of America
Bank of America
North Carolina
-$5.37K
5
Osaic Holdings
Osaic Holdings
Arizona
-$1.91K

PXMD Hedge Fund Activity: Q2 2023 in Review

8 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in PaxMedica, Inc. Common Stock (PXMD) for Q2 2023, worth a combined $165K — down 46% from $308K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PXMD and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $99.5K. The largest seller was UBS Group, exiting entirely with an estimated $33.9K sold.

  • 8 institutional investors held PaxMedica, Inc. Common Stock (PXMD) as of Q2 2023, down from 10 in Q1 2023.
  • Funds reported $165K of PaxMedica, Inc. Common Stock stock for Q2 2023, down 46% quarter-over-quarter.
  • 2 funds opened new PaxMedica, Inc. Common Stock positions in Q2 2023 and 4 closed out, a net change of -2 holders.
  • The largest PaxMedica, Inc. Common Stock buyer in Q2 2023 was Citadel Advisors, an estimated $99.5K added.
  • The largest PaxMedica, Inc. Common Stock seller in Q2 2023 was UBS Group, an estimated $33.9K sold.

Based on aggregated 13F filings for Q2 2023.